Zimmer Biomet Holdings (ZBH) Free Cash Flow (2009 - 2026)

Zimmer Biomet Holdings has reported Free Cash Flow for 18 years, with the latest figure at $323.1 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow fell 4.46% year-over-year to $323.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (changed 0.23% YoY), and the FY2025 full-year result was $1.5 billion, up 13.66% from the prior year.
• Free Cash Flow for Q1 2026 stood at $323.1 million, down from $442.6 million in the prior quarter.
• The five-year high for Free Cash Flow was $525.6 million in Q4 2023, with the low at $172.9 million in Q1 2024.
• Average Free Cash Flow over 5 years is $326.5 million, with a median of $323.1 million recorded in 2026.
• Year-over-year, Free Cash Flow plunged 37.31% in 2022 and surged 190.71% in 2023.
• Tracing ZBH's Free Cash Flow over 5 years: stood at $180.8 million in 2022, then soared by 190.71% to $525.6 million in 2023, then retreated by 13.47% to $454.8 million in 2024, then retreated by 2.68% to $442.6 million in 2025, then declined by 27.0% to $323.1 million in 2026.
• The last three Free Cash Flow figures came in at $323.1 million (Q1 2026), $442.6 million (Q4 2025), and $363.7 million (Q3 2025), per Business Quant data.

Peer Comparison